Northwest Biotherapeutics soars, article draws Onyx comparison

|About: Northwest Biotherapeutics, ... (NWBO)|By:, SA News Editor

Shares of Northwest Biotherapeutics (NWBO +25.7%) are moving sharply higher on triple their 10-day average volume.

Likely helping the cause is SA contributor Josh Ginsburg who says the company "poses Onyx like potential."

Ginsburg also calls pre-clinical animal studies of DCVax-Direct "the most impressive data from any cancer study [he has] ever seen."